Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Core Viewpoint - Xeris Biopharma Holdings, Inc. has granted restricted stock units to new employees as part of its Inducement Equity Plan, indicating a commitment to attract talent and enhance its workforce [1] Group 1: Company Actions - On January 2, 2026, Xeris granted restricted stock units for a total of 181,550 shares of common stock to 50 new employees [1] - The stock grants are part of Xeris' Inducement Equity Plan, which aims to incentivize and retain key personnel [1]